2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 17- Coagulation and Thrombosis II (Xeno Track)

36.508 - Circulating microparticles plasma levels in primates recipients of hDAF and GalT-KO pig kidney

Presenter: Elena, Campello, Padua, Italy
Authors: Claudia Maria Radu1, Elena Campello1, Luca Spiezia1, Cristiana Bulato1, Sabrina Gavasso1, Lucrezia Furian2, Emanuele Cozzi2,3, Paolo Simioni1

508

Circulating microparticles plasma levels in primates recipients of hDAF and GalT-KO pig kidney

Claudia Maria Radu1, Elena Campello1, Luca Spiezia1, Cristiana Bulato1, Sabrina Gavasso1, Lucrezia Furian2, Emanuele Cozzi2,3, Paolo Simioni1

1Cardiologic, Thoracic and Vascular Sciences, University of Padua; 2Surgical and Gastrointestinal Sciences, University of Padua; 3Consortium for Research in Organ Transplantation (CORIT); Padua, Italy

 

Introduction: Activation of the clotting cascade, fibrin deposition and thrombosis are key features of the rejection process that takes place in xenotransplantation. In order to prevent acute humoral xenograft rejection due to immunological barrier, human decay-accelerating factor (hDAF) and a1,3-galactosyltransferase gene knockout (GalT-KO) pigs are used, but all graft from these transgenic pigs underwent rejection exhibiting thrombotic microangiopathy with platelets-rich fibrin thrombi in the microvasculature. The exact mechanisms by which coagulation activation is induced after xenotransplantation remain unclear. Microparticles (MPs) are small vesicles shed from the surface of activated or apoptotic cells that have a procoagulant activity.

Aim of the study: In human, increased levels of circulating MP are associated with a prothrombotic state We measured and characterised circulating MPs plasma levels in monkeys before and after pig hDAF and GalT-KO kidney xenotransplantation.

Materials and Methods: Blood samples were obtained at time of euthanasia from 20 healthy monkeys, 10 after hDAF and 10 after GalT-KO kidney xenograft. MPs were analyzed by flow cytometry (FC500 Cytomics, USA), with a gate defined by 1µm beads (Megamix, Stago, France) and using FITC-Annexin V, PC5-anti-CD61, PE-anti-CD62P (P-Selectin), PE-antiCD62E (E-Selectin MP) and PE-anti-CD142 antibodies in order to identify apoptotic, platelets, endothelial and tissue factor bearing MPs, respectively.

Results: The total MPs plasma levels (mean±SD) and the subgroups of MPs in total study population are summarize in Fig 1.

Conclusion: The results demonstrateddecreased circulating MPs derived from apoptotic, activated endothelial cells and TF bearing MPs in the two groups of transplanted monkeys as compared to controls. In GalT-KO kidney xenograft animals the decreased of circulating MPs are higher than hDAF transplanted animals.

The reduction of circulating cells derived in GalT-KO as compared to hDAF kidney transplanted monkeys at euthanasia may be due to a major activation of clotting cascade causing consumption of the coagulation factors.

 

Apoptotic Mps

(mean±SD)

Platelets MPs

(mean±SD)

Endothelial MPs

(mean±SD)

TF-bearing MPs

(mean±SD)

GalT-KO (MPs/uL)

19216± 9100*

10053±6985**

171±90**

91±45*

h-DAF

(MPs/uL)

13825±5077

7019±4026†††

197±46††

86±33

Controls

(MPs/uL)

31224±8668

34753±10186

325±94

126±18

 

* p = ns ** p < 0.001 GalT-KO vs controls

† p = ns †† p < 0.05 ††† p < 0.001 h-DAF vs controls


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada